Loading...
Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
INTRODUCTION: The toxic side effects of doxorubicin (DOX) have limited its use in chemotherapy. Neither liposomal DOX nor pegylated liposomal DOX are able to completely resolve this issue. This is a proof-of-concept study testing aptamer-drug conjugate (ApDC) targeted delivery systems for chemothera...
Na minha lista:
| Udgivet i: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5804143/ https://ncbi.nlm.nih.gov/pubmed/29440899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S149887 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|